Amyotrophic lateral sclerosis (ALS) is a severe disease that causes thousands of deaths annually. Current treatments are either limited in effectiveness or not broadly applicable. To discover new options, we conducted a genetics-based screen to identify drugs that could be repurposed for ALS. We analyzed genome-wid...
S. Saez-Atienzar, Luis A. Rojas-Colón, Ruth Chia et al.· npj Digital Medicine· 0 citations
Greater TDP-43 burden was most closely associated with antemortem clinical decline rather than cumulative aggregation through the disease course, suggesting that the temporal dynamics of protein aggregation may differ among FTLD proteinopathies, with implications for the interpretation of FTLD-Tau and FTLD-TDP‑specific...
R. Magee, Sharon X. Xie, DT Ohm et al.· Neurology· 1 citation
The data show that activated microglial phenotypes in the CA2 of LBD patients are associated with worse clinical outcomes and retrograde n-asyn transmission, and suggest that measures of microglial states can refine LBD histopathological progression models.
Esteban Luna, K. Cousins, Sheina Emrani et al.· Acta Neuropathologica· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.